AAM
ZBH icon

Azzad Asset Management’s Zimmer Biomet ZBH Stock Holding History

Azzad Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,437
Closed -$678K – 365
2025
Q2 		$678K Buy
7,437
+203
+3% +$19.6K 0.07% 258
2025
Q1 		$819K Buy
7,234
+84
+1% +$8.99K 0.1% 237
2024
Q4 		$755K Buy
7,150
+131
+2% +$14.1K 0.15% 134
2024
Q3 		$758K Buy
7,019
+144
+2% +$15.7K 0.09% 245
2024
Q2 		$746K Buy
6,875
+33
+0.5% +$3.89K 0.09% 240
2024
Q1 		$903K Sell
6,842
-108
-2% -$13.5K 0.11% 225
2023
Q4 		$846K Buy
6,950
+123
+2% +$13.7K 0.11% 229
2023
Q3 		$766K Buy
6,827
+1,495
+28% +$190K 0.11% 232
2023
Q2 		$776K Buy
5,332
+40
+0.8% +$5.44K 0.1% 241
2023
Q1 		$684K Buy
5,292
+73
+1% +$9.16K 0.1% 243
2022
Q4 		$665K Buy
5,219
+80
+2% +$9.28K 0.11% 233
2022
Q3 		$537K Buy
5,139
+71
+1% +$7.79K 0.05% 335
2022
Q2 		$532K Buy
5,068
+128
+3% +$15.2K 0.05% 337
2022
Q1 		$632K Sell
4,940
-9,348
-65% -$1.13M 0.09% 259
2021
Q4 		$1.76M Sell
14,288
-947
-6% -$124K 0.24% 164
2021
Q3 		$2.16M Buy
15,235
+5,614
+58% +$826K 0.32% 122
2021
Q2 		$1.5M Buy
9,621
+6,066
+171% +$983K 0.22% 177
2021
Q1 		$552K Buy
+3,555
New +$551K 0.09% 269
2015
Q3 		– Sell
-3,779
Closed -$401K – 261
2015
Q2 		$401K Sell
3,779
-63
-2% -$6.97K 0.2% 186
2015
Q1 		$438K Buy
3,842
+142
+4% +$16.2K 0.21% 182
2014
Q4 		$407K Buy
3,700
+201
+6% +$21.2K 0.22% 189
2014
Q3 		$342K Sell
3,499
-561
-14% -$55.2K 0.2% 207
2014
Q2 		$409K Buy
4,060
+29
+0.7% +$2.83K 0.25% 161
2014
Q1 		$370K Buy
4,031
+280
+7% +$25.8K 0.24% 179
2013
Q4 		$339K Buy
3,751
+317
+9% +$27.4K 0.25% 168
2013
Q3 		$274K Hold
3,434
– – 0.22% 183
2013
Q2 		$274K Buy
+3,434
New +$257K 0.23% 179

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Azzad Asset Management's ZBH Position: Q3 2025 in Review

Azzad Asset Management sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 7,437 shares — an estimated $678K sold.

Azzad Asset Management first reported a position in ZBH in Q2 2013 and held it in 27 quarters. The position peaked at $2.16M in Q3 2021. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.

  • Azzad Asset Management reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
  • Azzad Asset Management sold 7,437 Zimmer Biomet shares in Q3 2025, an estimated $678K.
  • Azzad Asset Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 27 quarters.
  • Azzad Asset Management's Zimmer Biomet position peaked at $2.16M in Q3 2021.
  • 966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.

Based on Azzad Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.